Skip to main content

Latest SEC Filings — Page 73

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

Officer Dennis Mulroy Files to Sell Additional $1.1M in Stock
Form 144ANAB · Form 144 · 10d ago
DHT Holdings Orders New VLCC, Formalizes $250M Credit Facility
Form 6-KDHT · Form 6-K · 10d ago
Avalo Therapeutics Grants Investor Increased Conversion Rights for Discounted Preferred Stock; Amends Executive Severance
ProForm 8-KAVTX · Form 8-K · 10d ago
Amerant Bancorp Files $300 Million Universal Shelf Registration, Increasing Capital Raising Capacity
Form S-3ASRAMTB · Form S-3ASR · 10d ago
Wheeler REIT Announces 1-for-4 Reverse Stock Split to Avoid Delisting
ProForm 8-KWHLR · Form 8-K · 10d ago
SAGTEC GLOBAL Grants $448K in Restricted Shares to CEO, CFO, CTO
Form 6-KSAGT · Form 6-K · 10d ago
Mercury General Completes $525M Senior Notes Offering, Amends Credit Agreement
ProForm 8-KMCY · Form 8-K · 10d ago
Carlyle Credit Income Fund Reports $3.54 NAV, Shares Trade at Extreme Premium to Asset Value
ProForm 8-KCCID · Form 8-K · 10d ago
Shareholders to Vote on Massive Dilution and Reverse Stock Split to Avoid Nasdaq Delisting
ProForm PRE 14ATNON · Form PRE 14A · 10d ago
Inflection Point VI Finalizes $1.2B SPAC Merger with Quantum Space, Secures $300M in Financing
ProForm 8-KIPFX · Form 8-K · 10d ago
Genasys Secures $4.3M High-Interest Loan with 3-Month Maturity Amid Liquidity Challenges
ProForm 8-KGNSS · Form 8-K · 10d ago
Avista Pauses 500 MW Data Center Negotiations Amid Community Concerns
ProForm 8-KAVA · Form 8-K · 10d ago
Repay Holdings Shareholders Approve Dilutive Incentive Plan, Re-elect Directors Amidst Activist Battle
ProForm 8-KRPAY · Form 8-K · 10d ago
Century Therapeutics Shareholders Approve 50% Increase in Authorized Common Stock
ProForm 8-KIPSC · Form 8-K · 10d ago
Soligenix Faces Nasdaq Delisting Threat and Terminates Lead Drug Program
ProForm 8-KSNGX · Form 8-K · 10d ago
Lipocine Re-Interprets Failed Phase 3 Data for LPCN 1154, Pursues NDA with FDA
ProForm 8-KLPCN · Form 8-K · 10d ago
SPAC Sets Shareholder Vote for Merger with Pre-Revenue Fusion Target; Warns of Going Concern Risk and Significant Dilution
ProForm 424B3SVAC · Form 424B3 · 10d ago
Officer Files Intent to Sell Shares Amidst Chapter 11 Bankruptcy Filing
Form 144SNBR · Form 144 · 10d ago
Silexion Therapeutics Registers Resale of 859,609 Shares for Selling Shareholders, Potential 76% Dilution
ProForm S-3SLXN · Form S-3 · 10d ago
Socket Mobile Removes CEO Kevin Mills, Appoints David A. Holmes Amidst Nasdaq Delisting Warning
ProForm 8-KSCKT · Form 8-K · 10d ago
Primary Refrigerant Facility Damaged by Storms, Operations Disrupted
ProForm 8-KHDSN · Form 8-K · 10d ago
Atara Biotherapeutics Appoints New Director, Approves 400K Share Equity Plan
Form 8-KATRA · Form 8-K · 10d ago
Arrive AI Launches $15M At-The-Market Offering Amidst Going Concern Warning
ProForm 8-KARAI · Form 8-K · 10d ago
Shareholders Approve 2.5M Share Increase for Incentive Plan
ProForm 8-KGIII · Form 8-K · 10d ago
SPAC Secures Extension with Extremely Low Redemptions, Bolstering Ace Green Recycling Merger
ProForm 8-KATEKU · Form 8-K · 10d ago
KALA BIO Amends $350M Shelf Registration to Reflect 1-for-50 Reverse Stock Split
Form S-3/AKALA · Form S-3/A · 10d ago
Avis Budget Group Issues $685.75M in Asset-Backed Securities for Fleet Financing
ProForm 8-KCAR · Form 8-K · 10d ago
La Rosa Holdings Faces New Nasdaq Delisting Threat Over Negative Equity
ProForm 8-KLRHC · Form 8-K · 10d ago
Major Shareholder Sells $23M in Redwire Stock via Cashless Warrant Exercise
Form 4RDW · Form 4 · 10d ago
Aardvark Therapeutics Awards $703.5K in Retention Bonuses to CFO/COO and CMO Amidst Clinical Hold
Form 8-KAARD · Form 8-K · 10d ago